Australian Operations
   
Include All CSL Behring Country Sites

Plasma Fractionation for Australia

CSL has been Australia’s national fractionator of plasma-derived therapies since 1952.

For further information visit the Australian Red Cross Blood Service website.

Today, Australian Governments continue to choose CSL Behring as Australia’s national plasma fractionator, and we are regulated by the Therapeutic Goods Administration, a regulator held in high regard worldwide.

Working together CSL Behring in Australia and the Australian Red Cross Blood Service ensure that the blood and plasma donations made voluntarily by Australia's community continue to deliver the benefits that self-sufficiency provides – a sustainable, reliable and high quality source of plasma-derived therapies, developed to treat serious medical conditions including immunodeficiencies, a range of haematological and neurological disorders, haemophilia, haemolytic disease of the newborn and trauma. 

CSL Behring also has the technology, understanding, experience and infrastructure necessary to develop and manufacture a range of specific immunoglobulins or ‘hyperimmunes’. The specific immunoglobulins made by CSL Behring protect Australia's population against infection by cytomegalovirus, hepatitis B virus, zoster (chickenpox) virus and tetanus. CSL Behring also manufactures Rh(D) Immunoglobulin to protect babies from haemolytic disease of the newborn. The same skills and technology that CSL Behring deploys to make the specific immunoglobulins could quickly be developed to protect the Australia's population from emerging diseases. 

For more information about these products, please refer to the table below.



A-Z of Australian products

 

A   B   C   E   H   I   M   N   P   R   T   Z  
Product Name Subcategory Description

A

ALBUMEX®  4
Critical Care
Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange.
ALBUMEX® 20
Critical Care
Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange.

B

BERINERT®
Critical Care
Used for the treatment of acute attacks in patients with hereditary angioedema.
BIOSTATE®
Coagulation Disorders
Used for patients with haemophilia A, in which there are reduced levels of factor VIII.

C

CMV Immunoglobulin-VF
Immune Therapy
Used to help prevent cytomegalovirus infection in specific transplant patients.

E

EVOGAM®
Immune Therapy
Used to treat people who need replacement of antibodies which form part of our immune system and can provide protection against some infections

H

Hepatitis B Immunoglobulin-VF
Immune Therapy
Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material.
Hizentra®
Immune Therapy
Used to treat patients who need replacement of antibodies. Antibodies are part of the immune system and help provide protection against infections.

I

INTRAGAM® P
Immune Therapy
Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders.
INTRAGAM® 10
Immune Therapy
Indicated to replace antibodies to help prevent infections and also in the treatment of some autoimmune disorders.

M

MonoFIX®-VF
Coagulation Disorders
Used in patients with haemophilia B, in which there are reduced levels of Factor IX.

N

Normal Immunoglobulin-VF
Immune Therapy
Used for the replacement of antibodies to help prevent infections.

P

Privigen®
Immune Therapy
Used to treat patients who need replacement of antibodies and for the treatment of some autoimmune disorders.
PROTHROMBINEX®-VF
Coagulation Disorders
Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X.

R

Rh(D) Immunoglobulin-VF
Immune Therapy
Used to prevent Haemolytic Disease of the Newborn.
RHOPHYLAC®
Immune Therapy
Used in large fetomaternal haemorrhage (FMH), or for inadvertent or emergency transfusion of Rh (D) positive blood to an Rh (D) negative female of childbearing potential.
RiaSTAP®
Coagulation Disorders
Used for treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency.

T

Tetanus Immunoglobulin-VF IM
Immune Therapy
Used to help prevent tetanus in a person who has not recently been immunised against tetanus.
Tetanus Immunoglobulin-VF IV
Immune Therapy
Used to treat tetanus infection.
THROMBOTROL®-VF
Critical Care
Used for the treatment of patients with conditions relating to an inherited deficiency of antithrombin III.

Z

Zoster Immunoglobulin-VF
Immune Therapy
Used to help prevent chickenpox and shingles.